期刊文献+

腺相关病毒载体介导siRNA抑制HBV的表达与复制 被引量:1

Inhibition of Hepatitis B Virus by Small Interfering RNA Expressed from Adenovirus-associated Virus Vectors
原文传递
导出
摘要 目的:构建并制备能够有效抑制HBV mRNA表达的siRNA-重组腺相关病毒。方法:将筛选到的siRNA片段克隆入骨架质粒pAAV-MCS中,与pAAV-RC和pHelper质粒共转染人胚肾293T细胞,包装出重组腺相关病毒,将纯化后的重组病毒直接感染HepG2.2.15细胞,通过酶联免疫法和荧光定量PCR法检测重组腺相关病毒的抑制效果。结果:重组腺相关病毒显著降低HBV分泌的相关抗原蛋白以及DNA和RNA水平。结论:重组腺相关病毒载体介导的siRNA能够有效抑制HBV的表达与复制。 Objective:To construct the recombinant Adenovirus-associated virus(AAV) vector for siRNA targeting HBV mRNA and to evaluate the inhibitive effect on Hep G 2.2.15 cell.Method:The packing cell line(human embryonic kidney 293T cell) was co-transfected with AAV backbone plasmid pAAV-MCS which has been cloned into the selected siRNA,along with the pAAV-RC and pHelper in AAV Helper-Free System.The recombinant adenovirus-associated virus was packaged and amplified,followed by infection of the Hep G 2.2.15 cells.The expression level of HBV gene and the replication of HBV were analyzed by ELISA and fluorescence quantitative RCR.Result:The recombinant adenovirus-associated virus vectors containing siRNA targeting HBV mRNA was successfully constructed.ELISA results demonstrated that the siRNA can effectively inhibit the secretion of HBsAg and HBeAg and the fluorescence quantitative RCR results also showed that the copies of HBV DNA and RNA were significantly reduced.Conclusion:The recombinant adenovirus-associated virus vector can effectively inhibit the expression and replication of HBV in vitro.
出处 《中国生物工程杂志》 CAS CSCD 北大核心 2010年第4期49-53,共5页 China Biotechnology
关键词 RNA干扰 HBV 腺相关病毒 基因治疗 RNA interference HBV Adenovirus-associated virus Gene therapy
  • 相关文献

参考文献12

  • 1Fire A, Xu S, Montgomery M K, et al. Potent and specific interference by double-stranded RNA in Caenorhabditis elegans. Nature, 1998, 391 (6669) :806-811.
  • 2Chen Y, Cheng G F, Ram I Mahato. RNAi for Treating hepatitis B viral infection. Pharmaceutical Research, 2008,25 ( 1 ) : 72 - 86.
  • 3Rudy J, Rowshon A, Vidula D, et al. Mechanisms and strategies for effective delivery of antisense and siRNA oligonucleotides. Nucleic Acids Research, 2008, 36(12) :4158-4171.
  • 4Grimm D, Kay M A. Therapeutic short hairpin RNA expression in the liver: viral targets and vectors. Gene Therapy, 2006,13 ( 2), 563 -575.
  • 5吴小兵,董小岩,伍志坚,屈建国,侯云德.一种快速高效分离和纯化重组腺病毒伴随病毒载体的方法[J].科学通报,2000,45(19):2071-2075. 被引量:75
  • 6Arbuthnot P, Longshaw V, Naidoo T, et al. Opportunities for treating chronic hepatitis B and C virus infection using RNA interference. Journal of Viral Hepatitis, 2007,14 ( 8 ) : 447 -459.
  • 7Wanga X L , Thanh N, David G, et al. A multifunetional and reversibly polymerizable earlier for efficient siRNA delivery. Biomaterials, 2008, 29 ( 1 ) : 15 -22.
  • 8Aouadi M, Gregory J T, Sarah M N. Orally delivered siRNA targeting macrophage Map4k4 suppresses systemic inflammation. Nature ,2009, 458 (7242) : 1180-1184.
  • 9Shyam D, Kenneth I, Berns. Gene therapy using adeno-associated virus vectors. Clinical Microbiology Reviews, 2008, 21 ( 4 ) : 583 - 593.
  • 10王启钊,吕颖慧,肖卫东,刁勇,许瑞安.重组腺相关病毒载体临床实验研究[J].中国生物工程杂志,2010,30(1):73-79. 被引量:12

二级参考文献42

  • 1王启钊,吕颖慧,许瑞安.基因治疗用腺相关病毒载体的剂量效应与剂量控制(英文)[J].中国临床药理学与治疗学,2008,13(10):1182-1194. 被引量:2
  • 2刁勇,许瑞安.细胞生物技术实验指南.北京:化学工业出版社,2008:221-261.
  • 3Xu R, Sun X, Tse LY, et al. Long-term expression of angiostatin suppresses metastatic liver cancer in mice. Hepatology, 2003, 37(6): 1451-1460.
  • 4Shi J, Zheng D, Liu Y, et al. Overexpression of soluble TRAIL induces apoptosis in human lung adenocarcinoma and inhibits growth of tumor xenografts in nude mice. Cancer Res, 2005, 65(5): 1687-1692.
  • 5Eberling JL, Jagust WJ, Christine CW, et al. Results from a phase I safety trial of hAADC gene therapy for Parkinson disease, hAADC. Neurology, 2008, 70(21): 1980-1983.
  • 6Hauswirth WW, Aleman TS, Kaushal S, et al. Treatment of leber congenital amaurosis due to RPE65 mutations by ocularsubretinal injection of adeno-associated virus gene vector: short-term results of a phase I trial. Hum Gene Ther, 2008, 19(10): 979-990.
  • 7Urabe M, Ding C, Kotin RM, et al. Insect cells as a factory to produce adeno-associated virus type 2 vectors. Hum Gene Ther, 2002, 13(16): 1935-1943.
  • 8Muzyczka N. Use of adeno-associated virus as a general transduction, vector for mammalian cells. Curr Top MicrobiolImmunol, 1992, 158: 97-129.
  • 9Xiao X, Li J, Samulski RJ. Production of high-titer recombinant adeno-associated virus vectors in the absence of helper adenovirus. J Virol, 1998, 72(3): 2224-2232.
  • 10Xu R, Janson, CG, Mastakov M, et al. Quantitative comparison of expression with adeno-associated virus (AAV-2) brain-specific gene cassettes. Gene Ther, 2001, 8(17): 1323-1332.

共引文献90

同被引文献16

引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部